Optimist Retirement Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
52,040
+479
+0.9% +$20.6K 0.96% 30
2026
Q1
$1.89M Buy
+51,561
New +$2.44M 0.84% 40
2024
Q4
Sell
-2,747
Closed -$327K 126
2024
Q3
$327K Buy
2,747
+112
+4% +$14.9K 0.15% 61
2024
Q2
$376K Buy
2,635
+300
+13% +$39.8K 0.2% 53
2024
Q1
$300K Buy
2,335
+83
+4% +$9.88K 0.15% 62
2023
Q4
$233K Buy
+2,252
New +$223K 0.15% 63

Other funds holding NVO

Optimist Retirement Group's NVO Position: Q2 2026 in Review

Optimist Retirement Group increased its Novo Nordisk (NVO) stake by 0.93% in Q2 2026, buying an estimated $20.6K and bringing the position to 52,040 shares worth $2.49M. The position accounts for 0.96% of the portfolio, ranked #30.

Optimist Retirement Group first reported a position in NVO in Q4 2023 and has held it in 6 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Optimist Retirement Group held 52,040 shares of Novo Nordisk worth $2.49M as of Q2 2026.
  • Optimist Retirement Group bought 479 Novo Nordisk shares in Q2 2026, an estimated $20.6K.
  • Novo Nordisk made up 0.96% of Optimist Retirement Group's portfolio in Q2 2026, its #30 holding.
  • Optimist Retirement Group first reported a position in Novo Nordisk in Q4 2023 and has held it in 6 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Optimist Retirement Group's 13F filing for Q2 2026, filed 10 Aug 2026.